Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

Sponsored by Boston Scientific

Anchorperson: D. Blackman

Spokesperson: R. Kharbanda

Summary

Cerebral embolic protection (CEP) remains a key consideration in modern TAVI procedures, as stroke continues to be one of the most serious complications. This EuroPCR 2025 session takes a close look at the latest data on CEP use in clinical practice, weighing where it fits best and for which patients it may offer the greatest benefit. It also reviews updated long-term outcomes with the ACURATE self-expanding valve platform and examines under-expansion issues through bench testing and simulation. With a forward-looking view on future treatment pathways, this session helps clarify how evolving technologies and strategies may shape TAVI care in the years ahead.

Learning Objectives

To discuss the latest clinical evidence related to cerebral embolic protection in TAVI
To review the most recent long term data on the ACURATE self-expanding valve platform
To understand the future treatment options for TAVI patients based on simulation

Speaker

D. Blackman

Welcome and session objectives